Transunion current report, 08 March 2016

TransUnion Form 8-K Summary

Business Context and Reporting Period

This Current Report on Form 8-K was filed by TransUnion on March 8, 2016, with a signature date of March 14, 2016. The filing reports the entry into a material definite agreement regarding an underwritten offering of common stock by selling stockholders, not the Company itself.

Key Financial Metrics

The filing does not provide standard financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The financial data presented relates exclusively to the terms of a secondary stock offering:

  • Shares Sold: 17,877,998 shares of Common Stock (15,652,500 initial + 2,225,498 via option exercise).
  • Offering Price: $25.00 per share.
  • Net Proceeds per Share: $24.0625 (net of underwriting discounts).
  • Proceeds Recipient: All net proceeds were received by the Selling Stockholders; the Company received no proceeds.

Material Changes

The primary material event is the completion of a secondary offering. On March 11, 2016, underwriters partially exercised their 30-day option to purchase an additional 2,225,498 shares. The total offering settled on March 14, 2016. This transaction increased the number of outstanding shares held by public investors but did not alter the Company's capital structure or cash position.

Guidance, Outlook, and Risks

The filing contains no management commentary, financial guidance, or outlook for future periods. It does not disclose new risks or contingencies beyond the standard terms of the Underwriting Agreement, which is incorporated by reference as Exhibit 1.1. No unusual items were reported.

Investor Verification Checklist

  • Confirm that the Company received zero proceeds from this transaction, as all funds went to Selling Stockholders.
  • Verify the total number of shares issued (17,877,998) to assess potential dilution impact on earnings per share.
  • Review the Underwriting Agreement (Exhibit 1.1) for specific lock-up provisions or representations made by the Selling Stockholders.
  • Check subsequent filings to determine if the remaining option shares (122,002) were ever exercised.